Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 19, 2018Journal of Clinical InvestigationOpen Access

HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers

View Full Paper
Ask AI
Bookmark
Share

Authors

RSRadwa SharafGLGuinevere Q. LeeXSXiaoming Sun

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sharaf et al. (2018) studied this question.

synapsesocial.com/papers/6a6b35e83e46b6df0af2fbbahttps://doi.org/10.1172/jci120549
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy2013 · 93 citations
  2. 2Correlates of Protective Cellular Immunity Revealed by Analysis of Population-Level Immune Escape Pathways in HIV-12012 · 114 citations
  3. 3Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase1995 · 1,164 citations
  4. 4B-108 Specific HIV integration sites are linked to clonal expansion and persistence of infected cells2016 · 296 citations
  5. 5HIV‐1 DNA burden dynamics in CD4 T cells and monocytes in patients undergoing a transient therapy interruption2004 · 18 citations